Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2008
10/30/2008WO2008069890A3 Adrenal grk2 activity as a therapeutic target for heart failure
10/30/2008WO2008067480A3 Myostatin inhibition for enhancing muscle and/or improving muscle function
10/30/2008WO2008051511A3 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/30/2008WO2008016490A3 Modified two-component gelation systems for the treatment of post-myocardial infarction
10/30/2008WO2007143681A3 Helper virus-free herpesvirus amplicon particles and uses thereof
10/30/2008WO2006083797A3 Improving and protecting cell therapy for neurological disorders including parkinson's disease
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269473 Expression vector comprising nucleotide sequences coding gag and pol proteins for as tool in improving exogenous gene expression
10/30/2008US20080269160 Immune response against antigen in vivo; gold particle bombardment, nucleotide sequence encoding chimeric protein, antigen in one nucleic acid in an adenoviral vector; chimeric protein is myristoylation membrane targeting region; AP1903 ligand-binding region; CD40 cytoplasmic polypeptide region
10/30/2008US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268030 Gene therapy for diabetic ischemic disease
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267931 Compositions for Silencing the Expression of Vdac1 and Uses Thereof
10/30/2008US20080267929 Use of stem cells to generate inner ear cells
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008DE102007020152A1 Mittel zur antiinfektiven Behandlung eines Patienten Anti-infective agent for treatment of a patient
10/30/2008CA2683083A1 Methods of diagnosing alzheimer's disease and markers identified by set association
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1984513A1 Method and apparatus for heat or electromagnetic control of gene expression
10/29/2008EP1474067B1 One dose vaccination with i mycoplasma hyopneumoniae /i
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1234044B1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
10/29/2008EP1222208B1 Polypeptide derivatives of parathyroid hormone (pth)
10/29/2008EP1208217B1 Antibody dependent enhancement (ade) of alphavirus infection
10/29/2008EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
10/29/2008EP1076564B1 Compositions for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/29/2008EP1037611B1 Biodegradable mixed polymeric micelles for gene delivery
10/29/2008EP1036180B1 Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd)
10/29/2008EP1035208B1 VARIANT LoxP SEQUENCES AND APPLICATION OF THE SAME
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same
10/29/2008EP0815205B1 Method for in vitro preconditioning of myoblasts before transplantation
10/29/2008CN101294158A Small numerator interference RNA for inhibiting vascellum endometrial hyperplasia
10/29/2008CN101293931A Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof
10/29/2008CN101293908A Modified oligonucleotides for telomerase inhibition
10/29/2008CN100429316C Recombination adenovirus and its application
10/29/2008CN100429315C Expression vectors comprising the MCMV IE2 promoter
10/29/2008CN100429313C Bacterial plasmids
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/29/2008CN100428961C Artificial recombination selection replication type adenovirus and application
10/28/2008US7442787 Polynucleotide
10/28/2008US7442784 For regulation of gene expression
10/28/2008US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
10/28/2008US7442551 Lentiviral packaging constructs
10/28/2008US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines
10/28/2008US7442377 Protective antigen of epstein barr virus
10/23/2008WO2008127675A1 Compositions and methods for retinal transduction and photoreceptor specific transgene expression
10/23/2008WO2008127587A2 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer
10/23/2008WO2008127296A2 Methods and compositions for treating tularemia
10/23/2008WO2008127285A2 Target peptides for ovarian cancer immunotherapy
10/23/2008WO2008126085A2 Method for treating bone marrow disorders
10/23/2008WO2008125985A2 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
10/23/2008WO2008125846A2 Genetic suppression and replacement
10/23/2008WO2008125836A2 Methods and uses related to rhbdl4
10/23/2008WO2008125720A1 Expression vectors which include the human pklr gene promoter and use thereof for preparing pharmaceutical compositions for somatic genetic therapy with specific expression in erythroid cells
10/23/2008WO2008124934A1 Constructs for enhancement of gene expression in muscle
10/23/2008WO2008124927A1 Sirna against thymidylate synthase and uses thereof in cancer treatment regimens
10/23/2008WO2008100555A3 Engineered lung tissue construction for high throughput toxicity screening and drug discovery
10/23/2008WO2008097926A3 Transient transfection with rna
10/23/2008WO2008070363A3 Intrabodies
10/23/2008WO2008063839A3 Targeted delivery of therapeutic agents with lyophilized matrices
10/23/2008WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)
10/23/2008US20080263689 Screening/monitoring rate of internalization of insulin receptors in insulin-stimulated hepatocytes; identifying modulators of insulin clearance and secretion; treating insulin resistance
10/23/2008US20080262444 Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment
10/23/2008US20080261912 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers
10/23/2008US20080261909 Gene Delivery to Organs
10/23/2008US20080261883 Runx3 gene showing anti-tumor activity and use thereof
10/23/2008US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/23/2008US20080261303 Method and medicament for inhibiting the expression of a given gene
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080260758 Cell which expresses granulocyte colony stimulating factor and is deficient in major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which stimulates immune response to cancer
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260741 Preventive and/or Therapeutic Agent for Cancer
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260715 Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
10/23/2008US20080260707 Isolated homozygous stem cells, differentiated cells derived therefrom and materials and methods for making and using same
10/23/2008US20080260705 Bioassay comprising monolayer of co-cultured cardiac myocytes and skeletal muscle myoblasts for use as models in identifying modulators of erratic heart beating; treating myocardial disorders
10/23/2008US20080260701 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy
10/23/2008US20080260693 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv)
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 870